家族性腺瘤样息肉病癌变术后伴腹腔内韧带样纤维瘤1例
A Case of Familial Adenomatous Polyposis with Postoperative Malignant Transformation Complicated by Intra-Abdominal Desmoid Tumor
摘要: 家族性腺瘤样息肉病(Familial Adenomatous Polyposis, FAP)是一种常染色体显性遗传疾病,由APC基因突变引发,导致结直肠内广泛腺瘤性息肉,40岁未干预者结直肠癌风险接近100%。韧带样型纤维瘤(desmoid tumor, DT))作为FAP的重要肠外并发症,发生率约10%~20%,多见于腹腔或腹壁,具有局部侵袭性,虽不转移但易侵犯重要脏器,导致脏器梗阻、缺血等并发症,是致死率仅次于结直肠癌的第二大因素。在影像学上极易与恶性肿瘤腹腔转移或淋巴结转移混淆,本文拟回顾性分析1例家族性腺瘤样息肉病癌变术后伴腹腔内韧带样纤维瘤病展示了这一诊断陷阱,并对其发病机制及病理、临床表现、影像学特征、治疗策略进行学习,强调了MRI在软组织分辨上的优势以及病理活检的重要性,对临床医生避免误诊和过度治疗(如不必要的再次根治性手术)具有警示和教育意义。
Abstract: Familial adenomatous polyposis (FAP) is an autosomal dominant inherited disorder caused by mutations in the APC gene, characterized by the development of numerous adenomatous polyps throughout the colorectum. Without prophylactic intervention, the lifetime risk of colorectal cancer approaches nearly 100% by the age of 40. Desmoid tumors (DTs), also known as desmoid-type fibromatosis, represent a major extraintestinal manifestation of FAP, with an incidence of approximately 10%~20%. They most commonly occur in the abdominal cavity or abdominal wall and exhibit locally aggressive behavior. Although DTs do not metastasize, they can invade adjacent vital organs, leading to complications such as organ obstruction and ischemia, and constitute the second leading cause of mortality in patients with FAP after colorectal cancer. Radiologically, intra-abdominal desmoid tumors are easily confused with malignant peritoneal metastases or lymph node metastases. In this study, we retrospectively analyze a case of intra-abdominal desmoid-type fibromatosis occurring after malignant transformation in a patient with familial adenomatous polyposis, illustrating this important diagnostic pitfall. Furthermore, we review the pathogenesis, pathological features, clinical manifestations, imaging characteristics, and therapeutic strategies of this condition. This case highlights the superiority of magnetic resonance imaging (MRI) in soft tissue characterization and underscores the critical role of pathological biopsy, providing important educational value for clinicians to avoid misdiagnosis and overtreatment, such as unnecessary repeat radical surgery.
文章引用:文双, 梁治平, 步军. 家族性腺瘤样息肉病癌变术后伴腹腔内韧带样纤维瘤1例[J]. 临床医学进展, 2026, 16(3): 193-199. https://doi.org/10.12677/acm.2026.163779

参考文献

[1] 葛赛, 王晰程. 家族性腺瘤性息肉病的诊疗进展[J]. 肿瘤综合治疗电子杂志, 2022, 8(1): 107-112.
[2] 汪昭明, 袁捷, 赵子夜, 于恩达. 家族性腺瘤性息肉病的结直肠外表现研究进展[J]. 山东医药, 2022, 62(11): 87-91.
[3] 葛赛, 王晰程. 家族性腺瘤性息肉病相关硬纤维瘤的分子机制及诊疗进展[J]. 结直肠肛门外科, 2023, 29(2): 103-109.
[4] 李舒, 方志伟. 硬纤维瘤治疗策略的变化及新进展[J]. 中国肿瘤临床, 2023, 50(3): 130-134.
[5] Desmoid Tumor Working Group (2020) The Management of Desmoid Tumours: A Joint Global Consensus-Based Guideline Approach. European Journal of Cancer, 127, 96-107.
[6] van Houdt, W.J., Husson, O., Patel, A., Jones, R.L., Smith, M.J.F., Miah, A.B., et al. (2019) Outcome of Primary Desmoid Tumors at All Anatomic Locations Initially Managed with Active Surveillance. Annals of Surgical Oncology, 26, 4699-4706. [Google Scholar] [CrossRef] [PubMed]
[7] Yang, W. and Ding, P. (2023) Update on Familial Adenomatous Polyposis-Associated Desmoid Tumors. Clinics in Colon and Rectal Surgery, 36, 400-405. [Google Scholar] [CrossRef] [PubMed]
[8] Nieuwenhuis, M.H., Casparie, M., Mathus‐Vliegen, L.M.H., Dekkers, O.M., Hogendoorn, P.C.W. and Vasen, H.F.A. (2010) A Nation‐Wide Study Comparing Sporadic and Familial Adenomatous Polyposis‐Related Desmoid‐Type Fibromatoses. International Journal of Cancer, 129, 256-261. [Google Scholar] [CrossRef] [PubMed]
[9] 黄远健, 胥子玮. 腹内型侵袭性纤维瘤的临床特征[J]. 中国肿瘤外科杂志, 2025, 17(1): 75-79, 86.
[10] 韩猛虎. 韧带样纤维瘤误诊临床分析[J]. 临床误诊误治, 2020, 33(6): 45-49.
[11] Gounder, M., Ratan, R., Alcindor, T., Schöffski, P., van der Graaf, W.T., Wilky, B.A., et al. (2023) Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors. New England Journal of Medicine, 388, 898-912. [Google Scholar] [CrossRef] [PubMed]
[12] Gounder, M.M., Mahoney, M.R., Van Tine, B.A., Ravi, V., Attia, S., Deshpande, H.A., et al. (2018) Sorafenib for Advanced and Refractory Desmoid Tumors. New England Journal of Medicine, 379, 2417-2428. [Google Scholar] [CrossRef] [PubMed]
[13] 李舒, 方志伟, 刘佳勇, 等. 多柔比星脂质体联合达卡巴嗪治疗不可手术切除硬纤维瘤的疗效初探[J]. 中国肿瘤临床, 2021, 48(14): 716-720.